Kyntra Bio (KYNB) Invested Capital (2016 - 2025)
Historic Invested Capital for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to -$17.0 million.
- Kyntra Bio's Invested Capital rose 9301.18% to -$17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.0 million, marking a year-over-year increase of 9301.18%. This contributed to the annual value of -$152.5 million for FY2024, which is 1533.52% down from last year.
- According to the latest figures from Q3 2025, Kyntra Bio's Invested Capital is -$17.0 million, which was up 9301.18% from -$149.3 million recorded in Q2 2025.
- Kyntra Bio's Invested Capital's 5-year high stood at $390.3 million during Q1 2021, with a 5-year trough of -$243.7 million in Q3 2024.
- Its 5-year average for Invested Capital is -$5.8 million, with a median of -$48.9 million in 2023.
- As far as peak fluctuations go, Kyntra Bio's Invested Capital plummeted by 51655.24% in 2023, and later surged by 9301.18% in 2025.
- Over the past 5 years, Kyntra Bio's Invested Capital (Quarter) stood at $229.1 million in 2021, then plummeted by 109.36% to -$21.4 million in 2022, then tumbled by 516.55% to -$132.2 million in 2023, then dropped by 15.34% to -$152.5 million in 2024, then soared by 88.83% to -$17.0 million in 2025.
- Its Invested Capital stands at -$17.0 million for Q3 2025, versus -$149.3 million for Q2 2025 and -$216.9 million for Q1 2025.